human immunodeficiency virus (HIV) infection have increased, in association with the availability of antiretroviral (ARV) therapy and the decrease of opportunistic infections. However, studies on cardiac complications in HIV patients in the various HIV clinical and immunologic categories have been limited. Furthermore, cardiac complications in Indonesian HIV-infected children have never been reported.
C hildren infected with human immunodeficiency virus (HIV) may develop a wide range of asymptomatic and symptomatic cardiac abnormalities, some of which are known to be associated with poor survival. been reported, including asymptomatic left ventricle (LV) dysfunction, dilated cardiomyopathy, congestive heart failure, and hypotensive pump failure, all with cardiac-associated mortality. 1-3 These abnormalities occur frequently as the prevalence of HIV infection among children is high and advances in therapy and management improve life expectancy. Children with HIV who survive longer are less likely to die of pulmonary disease or infection, but more likely to die of cardiac causes. [4] [5] [6] The ability to identify patients at particularly high risk for cardiovascular abnormalities would improve survival and quality of life because care of HIV-infected patients relies on accurate diagnosis and prompt management of underlying illnesses, including symptomatic cardiac diseases. common in HIV-infected children. The mean values for numerous cardiac echocardiographic parameters are significantly different from normal at baseline and may be used to predict adverse outcomes independently, as well as identify high-risk groups to target for early intervention and therapy. Echocardiographic abnormalities are common, persistent, and often progressive in children with HIV infection. 7 dimension according to clinical classification of HIV factors for advanced cardiac involvement in HIVinfected children relating to HIV clinical category have been reported, including in those with HIV those who are asymptomatic or those with normal
The purpose of this study was to determine the prevalence of cardiac abnormalities in children with HIV infection and to compare their ventricular function and dimensions according to HIV clinical and immunological categories. of subjects had normal nutritional status and only 5 (severely symptomatic). No subjects were in the N (not symptomatic) category (Figure 1) . Based one of three categories: (1) without immunologic mm 3 3 ). Ninety percent of children were on first-line ARV treatment, while none received protease inhibitors. No significant differences in age, weight, height, and body surface area were found among HIV clinical categories 19.8 to 21.9 5.5 -6.2 8.3 -9.1 6.3 -6.9 8.4 to 9.1 LV: left ventricle, LVEDD: left ventricular end diastolic dimension, LVESD: left ventricular end systolic dimension, LVPWD: left ventricular posterior wall diastolic thickness left ventricular posterior wall systolic thickness, IVSD: interventricular septum diastolic thickness, interventricular septum systolic thickness. No electrocardiogram abnormalities were found in our subjects. Echocardiography revealed dilatation of the left atrium and ventricle in 3 children, as well as mild pericardial effusion in 6 children. Neither moderate or large pericardial effusions, nor vegetations chamber dilatation took anti-cardiac failure drugs. Mean left ventricular systolic and diastolic function, right ventricular function, and mean left ventricular dimensions were within normal ranges, except for higher than normal. Tables 1 and 2 show the results of left ventricular dimensions and ventricular function for all subjects.
Methods
Assessment of the cardiac valves revealed no congenital anomalies. Trivial tricuspid regurgitation moderate TR in 1 (peak gradient 34 mmHg). Mild mitral regurgitation was found in 5 subjects, trivial documented in the medical records. There were no significant differences in ventricular function and suppression (Tables 3 and 4).
HIV clinical category which consisted of categories
There were no statistically significant differences in LV function, RV function, LV dimension, and LV mass among the clinical categories (Tables 5 and 6). -13.9 to 5.9 -4.2 to 1.4 -3.3 to 0.9 -0.8 to 0.7 -0.9 to 0.7 -0.7 to 0.6 -0.8 to 0.5 LV: left ventricle, LVEDD: left ventricular end diastolic dimension, LVESD: left ventricular end systolic dimension, LVPWD: left ventricular posterior wall diastolic thickness left ventricular posterior wall systolic thickness, IVSD: interventricular septum diastolic dimension, interventricular septum systolic dimension. -3.2 to 2.2 -3.5 to 4.5 -9.5 to 0.5 -0.5 to 0.7 -0.7 to 1.1 -14.5 to 1.3 -5.4 to 8.3 -0.26 to 0.19 -0.035 to 0.0004 -2.8 to 0.9 EF: ejection fraction, FS: fractional shortening, CO: cardiac output (L/minute), CI: cardiac index (L/minute/m 2 ), SV: stroke volume, E: E wave peak velocity, A: A wave peak velocity, DT: deceleration time, TAPSE: tricuspid annular plane systolic excursion
Discussion
The prevalence of LV dysfunction in this study was function, LV mass, and cardiac dimensions in the 74 HIV-infected children in our study were in the normal range, according to normal reference values, except
Al-Attar et al. reported that of children who died with Ten percent of children who had CHF required cardiac medications
The prevalence of LV enlargement in a previous A previous study reported that the mean values for various cardiac parameters were significantly different from normal at baseline, and most remained so throughout follow-up, with some progressing. 7 The lower rate of LV dysfunction or enlargement in our study may relate to different population characteristics. Most of our subjects did not show any signs and symptoms of heart failure (subclinical heart impairment), while subjects of previous studies were mostly symptomatic, although they did not meet of subjects, sampling methods, and study design may also have influenced the results. The severity of LV dysfunction may be an important indicator for future survival.
year in patients with previously normal LV function. -0.9 to 5.4 -3.1 to 6.4 -8.6 to 3.7 -1.18 to 0.3 -1.3 to 0.9 -4.35 to 14.4 -6.9 to 9.4 -0.27 to 0.25 -0.01 to 0.03 -2.9 to 1.5 EF: ejection fraction, FS: fractional shortening, CO: cardiac output, CI: cardiac index, SV: stroke volume, E: E wave peak velocity, A: A wave peak velocity, DT: deceleration time, TAPSE: tricuspid annular plane systolic excursion.
could have contributed to our differing results. Cardiac disease in HIV-infected children as an underlying cause from cardiac disease is not seen in infancy, is unusual 6 Follow-up checks are mandatory to investigate future cardiac problems in our study patients as they get older.
The course of HIV-infection may contribute to heart disease, beginning with a catastrophic condition affecting all organs, including the heart. ARV administration may improve cardiac condition. 4 increased age are likely to become more important clinically as more patients survive their early years with the concomitant decreased risk of death from infection and pulmonary disease. Knowledge of specific agerelated causes of mortality can guide efforts in the care of HIV-infected children. 6 LV diastolic function in our study was in the normal range. Nor did we find abnormal relaxation or restrictive features which differed among HIV mitral valve E wave peak velocity being higher than the normal reference value, LV diastolic function was still preserved in these children. There had been no previous studies on diastolic dysfunction in HIV-infected children. Multiple factors associated with LA and LV that influence transmitral inflow could result in different diastolic function patterns. Further prospective study is required to assess diastolic function of HIV-infected children.
In the majority of our study subjects, RV function and symptoms of RV dysfunction. Interestingly, RV dysfunction was more frequent than LV dysfunction. Associated factors that influence RV function are chronic and recurrent lung infection, and in fact, most of our subjects were on anti-tuberculosis treatment. Further studies are needed to find out what factors could contribute to these results. The limitations, including its single dimensional approach, which assesses regional RV function rather than global has advantages since it is a simple, easy procedure that is highly reproducible. Also, it correlates with 13 normal values. This finding was similar to previous may result from a normal but inadequate response to persistent LV dilatation. The ratio of LV thickness to dimension reduction results in increased peak wall stress. Elevated peak wall stress normally induces LV hypertrophy until the LV thickness-to-14 inadequate hypertrophic response to LV dilatation. Catecholamine in HIV-infected children has been reported to be increased, inducing LV hypertrophy associated with hyperdynamic LV function. Chronic catecholamine elevation, in fact may result in LV dysfunction. 1 We found no significant differences in ventricular HIV clinical categories. A previous study with a small number of subjects reported hypertrophy and dilatation of LV, found mostly in the C clinical category. as a predictor of cardiac complications or cardiac death. A previous study revealed no significant correlation between cardiac and immune dysfunction, infection. 7 count as a marker for clinical outcome has limitations.
and cardiac assessment is one such limitation in our study. There was also discrepancy between clinical category determined at time of diagnosis and clinical condition at time of enrollment into this study. Most subjects had been improving clinically after ARV treatment. Early cardiac intervention also reduces subsequent cardiac morbidity and related mortality in HIV-infected children. The levels of lymphocyte subpopulations or combinations of surrogate markers, including the determination of viral load, may be more useful for determining the progression of cardiac disease in HIV-infected children.
Inflammation of the heart is commonly reflected by pericardial effusion, valve regurgitation, or ventricular dysfunction. A previous study reported infected children, higher than that of our study (6 severe effusions resulting in right atrium diastolic compression, some requiring pericardiocentesis. Most patients with moderate or severe effusion are not clinically distressed, but are at risk of lifethreatening tamponade. Echocardiography is justified for surveillance in HIV-infected patients, especially tuberculosis, or other pulmonary infections. 15 We found 17 children with moderate tricuspid regurgitation without RV dilatation, 5 children with mitral regurgitation, and 4 children with pulmonary tricuspid valve is more commonly involved compared to the mitral valve. However, tricuspid regurgitation is not always related to pathological conditions, though sometimes it can be associated with pulmonary hypertension. 16 et al regurgitation. We also found no congenital heart disease in our subjects. A previous study reported no significant difference in the prevalence of congenital heart disease between HIV-infected children and those without infection, but born of HIV-infected mothers. 17 Although the echocardiograms of our subjects were mostly normal, another study reported that echocardiography measures of LV structure and function are independent and potentially useful long-term and short-term predictors of overall congestive heart failure may be difficult in children with HIV infection because other diseases also can cause tachycardia, tachypnea, and hepatomegaly, thus increasing reliance on clinical judgment of the caregiver. Echocardiography measurement of LV structure and performance provides noninvasive, independent markers of disease and death in HIV-echocardiograms of this population may identify children at risk who may benefit from more careful examination and interventions to alter the course of the disease.
Fractional shortening may also be used as an important predictor for early death in HIV-infected children, as it represents the end result of multiple processes, including preload, after load, heart rate, and contractility. 3 Further study is needed to provide normal standard echocardiography references for Indonesian children. More studies are also required to determine whether early change in cardiac dimension in the baseline echocardiography of HIV-infected children is associated with increased cardiac morbidity and mortality and whether treatment of this kind of abnormality is beneficial.
In conclusion, the prevalence of LV dysfunction LV dimension or ventricular function among HIVinfected children among the different HIV clinical or immunological categories. Further prospective studies are needed to assess cardiac problems and to develop a national, baseline cardiovascular database of children with HIV infection. 
